Navigation Links
Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development
Date:1/11/2012

PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Premier Research Group announces the appointment of Susan C. Stansfield, PhD to the position of Executive Vice President, Clinical Development. In this position, Dr. Stansfield will have global responsibility for leading and developing the company's clinical trial management services provided to the biopharmaceutical industry.

"Sue's deep industry knowledge and proven leadership skills will be pivotal in enhancing the value our clinical development organization provides to our customers," commented Dr. Ludo Reynders, Chief Executive Officer. "As demand for our services continues to grow, Sue will focus on ensuring that scientific and operational excellence remains at the heart of our organization. Sue's exceptional skills and experience in the areas of program and project management will be invaluable in providing superior and appropriate services to our customers in today's rapidly changing drug development world."

Dr. Stansfield comes to Premier Research with an exceptional track record of more than 25 years in the pharmaceutical and contract research industries. Dr. Stansfield worked at three of the leading clinical service organizations (PRA, PPD and Quintiles) taking increasingly responsible leadership roles in project management and clinical operations. This included responsibility for 2,000 staff located in 50 countries. Dr. Stansfield holds a Doctorate in Neuropharmacology from Reading University in the UK and a Bachelor in Science from Nottingham University.

About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide.  The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.

The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.

For more information please visit, www.premier-research.com.


'/>"/>
SOURCE Premier Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Micronutrient Launches Supplement for Hearing Health
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Expands its Medical Device Operations to the United States
7. Premier Research Announces Milestone Investigational New Drug Application
8. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
9. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
10. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
11. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Pa. , Dec. 9, 2016 Department ... announced temporary regulations for medical marijuana dispensaries under Act ... Pennsylvania Bulletin , and are now available online ... is needed in the plan for operation; process for ... dispensary; as well as where the dispensary facilities can ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016 IRIDEX Corporation ... to offer newly issued shares of common stock, $0.01 par ... to an underwritten public offering.  The final terms of the ... time of pricing, and there can be no assurance as ... IRIDEX expects to use the net proceeds it will ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... ... such as reducing loss of blood during surgeries, lowering the ... surgeries, and decreasing risks of SSIs. The patient warming systems ... and intravascular warming systems.These benefits in turn reduce the stay ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
(Date:12/8/2016)... San Francisco, California (PRWEB) , ... December 08, 2016 , ... ... health coaches, has raised an $18M Series B led by Canvas Ventures . ... use the capital to scale its mobile platform to serve more consumers who are ...
Breaking Medicine News(10 mins):